Dr. Tariro Makadzange
Founder & CEO, Africa Clinical Research Network (ACRN)
Africa Clinical Research Network
Dr. Tariro Makadzange to Shape the Future of PAHCS
The launch of the Pan-African HIV Clinicians Society (PAHCS) in Addis Ababa represents a pivotal moment in Africa’s journey toward clinical leadership and collaboration in HIV care. Among the distinguished speakers is Dr. Tariro Makadzange, recently named to the TIME100 Health 2026 list, an acknowledgement of her growing global influence in advancing equitable healthcare.
Dr. Makadzange is the Founder and CEO of the Africa Clinical Research Network (ACRN), an initiative designed to transform the clinical research landscape across the continent. Despite Africa carrying a significant burden of disease, it remains underrepresented in global clinical trials. Through ACRN, she is building a pan-African ecosystem that connects institutions, strengthens research capacity, and enables African-led trials. This work is critical in ensuring that innovations in HIV treatment and prevention are relevant, accessible, and driven by local expertise.
Her participation in the PAHCS launch is both strategic and symbolic. PAHCS was established to unify African clinicians, strengthen education, and promote research and policy leadership in HIV care. Dr. Makadzange’s work aligns seamlessly with this mission, particularly her focus on shifting Africa from being a participant in global health research to becoming a leader in it.
At PAHCS, her contribution is expected to have far-reaching impact. She brings a unique ability to bridge clinical practice with cutting-edge research, ensuring that scientific advancements translate into real improvements in patient care. Her experience across academia, clinical medicine, and global health systems positions her as a powerful voice in shaping the society’s research agenda.
Importantly, her presence will inspire a new generation of African clinicians. By demonstrating that world-class research and leadership can be built from within the continent, she reinforces PAHCS’s commitment to mentorship, training, and sustainable capacity building.
Beyond the launch, Dr. Makadzange’s involvement signals the type of partnerships PAHCS seeks to cultivate, collaborations that are innovative, African-led, and globally relevant. Her work in advancing HIV research, vaccine development, and clinical trials will help position PAHCS as a key player in the global health landscape.
As PAHCS begins its journey, the inclusion of leaders like Dr. Makadzange ensures that it does so with vision, credibility, and momentum, firmly placing Africa at the centre of shaping its own healthcare future.
The launch of the Pan-African HIV Clinicians Society (PAHCS) in Addis Ababa represents a pivotal moment in Africa’s journey toward clinical leadership and collaboration in HIV care. Among the distinguished speakers is Dr. Tariro Makadzange, recently named to the TIME100 Health 2026 list, an acknowledgement of her growing global influence in advancing equitable healthcare.
Dr. Makadzange is the Founder and CEO of the Africa Clinical Research Network (ACRN), an initiative designed to transform the clinical research landscape across the continent. Despite Africa carrying a significant burden of disease, it remains underrepresented in global clinical trials. Through ACRN, she is building a pan-African ecosystem that connects institutions, strengthens research capacity, and enables African-led trials. This work is critical in ensuring that innovations in HIV treatment and prevention are relevant, accessible, and driven by local expertise.
Her participation in the PAHCS launch is both strategic and symbolic. PAHCS was established to unify African clinicians, strengthen education, and promote research and policy leadership in HIV care. Dr. Makadzange’s work aligns seamlessly with this mission, particularly her focus on shifting Africa from being a participant in global health research to becoming a leader in it.
At PAHCS, her contribution is expected to have far-reaching impact. She brings a unique ability to bridge clinical practice with cutting-edge research, ensuring that scientific advancements translate into real improvements in patient care. Her experience across academia, clinical medicine, and global health systems positions her as a powerful voice in shaping the society’s research agenda.
Importantly, her presence will inspire a new generation of African clinicians. By demonstrating that world-class research and leadership can be built from within the continent, she reinforces PAHCS’s commitment to mentorship, training, and sustainable capacity building.
Beyond the launch, Dr. Makadzange’s involvement signals the type of partnerships PAHCS seeks to cultivate, collaborations that are innovative, African-led, and globally relevant. Her work in advancing HIV research, vaccine development, and clinical trials will help position PAHCS as a key player in the global health landscape.
As PAHCS begins its journey, the inclusion of leaders like Dr. Makadzange ensures that it does so with vision, credibility, and momentum, firmly placing Africa at the centre of shaping its own healthcare future.
